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The present study investigated whether intrinsic fatigability of the muscle ﬁbers is reduced in patients with post-polio syndrome (PPS).
This may contribute to the muscle fatigue complaints reported by patients with PPS. For this purpose, we assessed contractile properties
and fatigue resistance of the knee extensor muscles using repeated isometric electrically evoked contractions in 38 patients with PPS and
19 age-matched healthy subjects. To determine whether any diﬀerence in fatigue resistance between both groups could be attributed to
diﬀerences in aerobic capacity of the muscle ﬁbers, 9 patients with PPS and 11 healthy subjects performed the same protocol under
arterial occlusion. Results showed that fatigue resistance of patients with PPS was comparable to that in controls, both in the
situation with intact circulation and with occluded blood ﬂow. Together, our ﬁndings suggest that there are no diﬀerences in
contractile properties and aerobic muscle capacity that may account for the increased muscle fatigue perceived in PPS.
 2013 Elsevier B.V. All rights reserved.
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Postpoliomyelitis syndrome (PPS) is a complex of late
onset neuromuscular symptoms with new or increased
muscle weakness and abnormal muscle fatigability as key
symptoms [1,2]. Knowledge about the origin of the
muscle fatigue perceived by patients with PPS is presently
limited. The muscle fatigue may result from the motor
unit reorganization and the altered pattern of activity
and function of the remaining muscle ﬁbers that occurred
during recovery from the acute polio and the secondary
decline [3].
Several adaptations have been described that may
change the fatigue resistance of the muscle ﬁbers in PPS0960-8966/$ - see front matter  2013 Elsevier B.V. All rights reserved.
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E-mail address: e.l.voorn@amc.uva.nl (E.L. Voorn).[4–6]. Mean muscle ﬁber cross-sectional area was found
to be about twice as large in patients with PPS compared
to healthy subjects, probably due to excessive use of
remaining ﬁbers [6]. Secondary to this hypertrophy, a
reduced capillary supply in relation to ﬁber area was
observed, that might impair diﬀusion capacity, leading to
shortage of substrate during muscle work. This
assumption is supported by the low aerobic enzyme
activity of the muscle ﬁbers [5]. A low capillary density in
combination with decreased aerobic enzyme capacity
would reduce fatigue resistance of the muscle ﬁbers.
Furthermore, a muscle ﬁber transformation from type II
ﬁbers to type I ﬁbers was reported, most likely also
resulting from overuse of the reduced muscle mass.
Contrary to the other adaptations, this would enhance
fatigue resistance [4–6]. Therefore, it remains unclear
whether the combination of these opposite adaptations
will enhance or reduce the fatigue resistance of the
muscle ﬁbers in patients with PPS compared to healthy
subjects [3].
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reported contradictory results. Some have shown that
muscles of patients with PPS are more fatigable than
muscles of healthy subjects, irrespective of strength [7–9],
while other studies reported no diﬀerences [10–13]. All
these studies have in common that voluntary contractions
were used to induce fatigue. Because fatigue is inﬂuenced
by both central neural and peripheral muscle factors, the
use of voluntary contractions complicates the search for
the relative contribution of each of these factors. The use
of electrically evoked contractions, an experimental
situation that completely removes the volitional element,
allows studying the intrinsic fatigability of the muscle
ﬁbers [14,15].
Our primary objective was to investigate fatigue
resistance of the knee extensor muscles in patients with
PPS during electrically evoked muscle contractions in
comparison with healthy subjects. The knee extensor
muscles were chosen, because muscle weakness in PPS
often aﬀects the lower limbs, and measurements can
accurately be performed on this muscle group that is of
major importance during locomotion-related activities
[16]. The second objective was to determine whether
diﬀerences in fatigability between both groups could be
attributed to diﬀerences in blood ﬂow or aerobic capacity
of the muscle. Therefore, we compared fatigue with an
intact circulation with fatigue under ischaemic conditions,
during which the ability for aerobic energy regeneration
was largely eliminated [17]. If diﬀerences in fatigue
resistance between PPS and healthy subjects during the
protocol with an intact circulation are attributed to
diﬀerences in aerobic muscle capacity or blood ﬂow then
no diﬀerences will be evident when the blood supply is
occluded.
2. Materials and methods
2.1. Subjects
A sample of 38 former polio patients who were
diagnosed with PPS according to the criteria published
by the March of Dimes participated in this study [1]. The
criteria for PPS are as following: (1) prior paralytic
poliomyelitis with evidence of motor neuron loss, as
conﬁrmed by history of the acute paralytic illness, signs
of residual weakness, and atrophy of muscles on
neurological examination, and signs of denervation on
electromyography (EMG), (2) a period of partial or
complete functional recovery after acute paralytic
poliomyelitis, followed by an interval (usually 15 years or
more) of stable neurologic function, (3) gradual or
sudden onset of progressive and persistent muscle
weakness or abnormal muscle fatigability (decreased
endurance), with or without generalized fatigue, muscle
atrophy, or muscle and joint pain, (4) symptoms persist
for at least 1 year, and (5) exclusion of other neurologic,
medical, and orthopedic problems as causes ofsymptoms. Patients were recruited from the Dutch expert
center for polio survivors of the Academic Medical
Center in Amsterdam. Twenty-eight of these patients
performed the measurements as part of an ongoing
clinical trial of the eﬃcacy of exercise therapy and
cognitive behavioral therapy to improve fatigue, daily
activity performance, and quality of life in PPS [18]. The
remaining 10 patients responded to an invitation after
chart review for eligibility. All patients were capable of
walking with or without walking aids and had minimum
knee extensor strength of 30 Nm in at least one leg,
assumed as minimal muscle strength for functional use.
In addition, healthy individuals, matched for age and
gender, who never had polio or any other neurological
disease served as controls. The control subjects were
recruited from employees of the university and others
who had responded to a recruitment advertisement for
the study. The study was approved by the medical ethics
committee of the Academic Medical Center (University
of Amsterdam, The Netherlands), and written informed
consent was obtained from all participants.
2.2. Instrumentation
Isometric torque recordings were made of maximal
voluntary and electrically evoked contractions of the knee
extensor muscles. Subjects were seated in a specially
designed dynamometer with a knee angle of 60 and a
hip angle of 100. The upper body and pelvis were
restrained with adjustable belts to prevent the hip from
extending when the knee extensor muscles contracted.
The lower leg was tightly strapped to a lever arm,
immediately proximal to the malleoli. The torque applied
by the knee extensor muscles was displayed on a screen,
digitized (1000 HZ), and stored on disk for oﬀ-line
analysis.
Electrical stimulation of the knee extensor muscles was
delivered through two self-adhesive surface electrodes
(8  13 cm, Schwa-medico, Leusden, The Netherlands)
placed over the proximal and distal part of the anterior
thigh. A personal computer running custom-made software
controlled the frequency and number of square-wave
pulses (200 ls) delivered by a constant-current high
voltage stimulator (model DS7H, Digitimer Ltd., Welwyn
Garden City, UK).
2.3. Procedure
In patients with PPS measurements were performed on
the leg which they felt was most limiting performance
during activities in daily life. However, if maximum knee
extensor strength in this leg was lower than 30 Nm,
measurements were performed on the other leg. In
healthy subjects, the leg on which measurements were
performed was selected randomly. Subjects performed
three maximal voluntary isometric knee extensions. They
received visual feedback of the torque and were verbally
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approximately 3 s, with 1 min of rest between
contractions. The highest torque was taken as the
maximal voluntary torque (MVT). Subsequently,
electrical bursts (150 Hz, to ensure maximal activation) of
1 s duration were delivered to the muscle with increasing
current until 30% of MVT was reached, suﬃcient to
activate a representative part of the muscle mass [19].
After a ﬁve-minute resting period, the resistance to
fatigue was determined by a series of electrically evoked
isometric contractions (50 Hz) of 1 s duration and 1 s of
rest in between for a period of ﬁve minutes (150
contractions). At this 50 Hz frequency, torque is
approximately 80–85% of the torque attained at 150 Hz,
and high frequency fatigue is prevented [20]. Subjects
were instructed to relax the muscles as much as possible
during the protocol. Recovery of fatigue, which depends
to a great extent on the aerobic capacity of the muscle
ﬁbers [21], was also monitored. This was done by
applying similar 1 s contractions (50 Hz) at diﬀerent times
(15, 30, 45, 90 and 180 s) after the end of the fatigue
protocol.
On an additional occasion, a subgroup of subjects, who
were willing to participate, performed the same fatigue test
under arterial occlusion. Three seconds prior to the
protocol, the blood ﬂow was occluded by rapid (<3 s)
inﬂation of a cuﬀ (Hokanson SC 10D, Bellevue, WA) to
a pressure of 250 mmHg. The occlusion was applied to
prevent the return of blood in the intervals between the
stimulated contractions and hence to prevent aerobic
energy regeneration [17]. To ensure that the cuﬀ did not
unwrap, an extra strap was secured around the cuﬀ
before inﬂation. When torque did no longer decline the
protocol was stopped and the cuﬀ was deﬂated.2.4. Data analysis
Oﬀ-line analysis of torque records was performed using
Matlab (Matlab, the Mathwork Inc., S. Natik, MA, USA).
Each torque signal was ﬁltered with a low-pass fourth
order Butterworth ﬁlter with a 50 Hz cut-oﬀ frequency.
The 50/150 Hz ratio and half-relaxation time (RT50)
were assessed in the pre-fatigue state as indices of
contractile speed of the muscle. Those muscles with faster
relaxation rates and lower 50/150 Hz ratios are assumed
to contain a higher proportion of fast twitch ﬁbers and
consequently will be less fatigue resistant [14,15]. RT50
was determined from the ﬁrst contraction (50 Hz) of the
fatigue protocol and was deﬁned as the time taken for
torque to decline from the value at the end of stimulation
to 50% of that value.
In the present study we focused on two important
properties that change during muscle fatigue: the decline
in torque-generating capacity and the slowing of
relaxation [20]. Peak torque and RT50 during the fatigue
protocol were expressed as a percentage of the valuesobtained in the ﬁrst contraction of the protocol (=100%)
to correct for torque diﬀerences among subjects. The
subsequent recovery of parameters was expressed as a
percentage of the diﬀerence between the ﬁrst and the
average of the last 15 contractions of the fatigue protocol.
2.5. Statistics
Statistical analysis was performed with the SPSS
statistical software package (version 19.0.0.1). Descriptive
data were expressed as mean and standard deviation
(demographic data) or as median and range (polio
characteristics). Diﬀerences with respect to demographic
data and pre-fatigue contractile characteristics (MVT,
RT50 and 50/150 Hz ratio) between patients with PPS
and healthy subjects were analyzed with the Student’s t
test. Dichotomized variables were analyzed with Fisher’s
exact test. A two-factor (“PPS” and “gender”) analysis of
variance, with repeated measures (“time”) was used to
test for signiﬁcant diﬀerences in the course of fatigue and
recovery. Gender was added as a factor since there are
sex diﬀerences in muscle fatigue resistance [22]. For the
standard fatigue protocol and the fatigue protocol under
arterial occlusion, total duration of the protocol was
divided into ﬁve equal intervals. Peak torque and RT50
values of the contractions corresponding to the resulting
six time points were accordingly used for analysis. An
alpha level of 0.05 was used for all tests of signiﬁcance.3. Results
3.1. Study group
Characteristics of patients with PPS and healthy control
subjects, both for the total study group (38 PPS, 19
control), and the subgroup performing the fatigue
protocol under occlusion (9 PPS, 11 control), are
presented in Table 1. Regular exercise (a minimum of
150 min per week with at least moderate intensity) was
reported by 11 healthy subjects and 6 patients with PPS.
All patients reported that they suﬀered from generalized
fatigue. Clinical signs of polio residuals in the lower
extremities, based on manual muscle testing, were present
in all, except 3 patients. No signiﬁcant diﬀerences were
found between patients with PPS performing the
occlusion measurements and those who did not, with
respect to demographic data and polio characteristics.
Some subjects had diﬃculty in relaxing the leg during
the stimulated fatigue protocol. This involuntary activity,
judged on basis of visual inspection of the data by
experienced investigators, sometimes caused unsteady
baseline torque resulting in unreliable measurements.
These results were therefore not included in the statistical
analysis, leading to diﬀerent numbers of observations for
diﬀerent parameters (the exact numbers used for analysis
are given in the legends with the ﬁgures).
Table 1
Subject characteristics and pre-fatigue contractile characteristics.
All subjects Subgroup (occlusion)
PPS (n = 38) Control (n = 19) PPS (n = 9) Control (n = 11)
Demographic data
Gender (male/female) 12/26 7/12 4/5 3/8
Age (yrs) 60.0 ± 6.6 59.0 ± 7.0 61.3 ± 6.7 60.3 ± 5.4
Body weight (kg) 76.1 ± 11.9 75.8 ± 9.4 77.3 ± 12.1 74.7 ± 10.1
BMI (kg/m2) 26.4 ± 2.9 24.8 ± 2.8 26.2 ± 1.9 24.8 ± 3.3
Polio characteristics
Age at acute polio (yrs) 2.0 (0–9) 2.0 (0–9)
Present walking distancea 3 (2–4) 4 (3–4)
Measured leg clinically aﬀected (yes/no) 27/11 5/4
Reported abnormal fatigue in measured leg (yes/no) 23/15 6/3
MMT knee extension measured leg (0–5) 5 (4- 5) 5 (4- 5)
MMT sum score legs (0–80)b 69.4 ± 8.6 71.3 ± 5.1
Pre-fatigue contractile characteristics
MVT (Nm) 106 ± 42c 179 ± 34 124 ± 69 172 ± 29
RT50 (ms) 127 ± 10 122 ± 8 124 ± 9 124 ± 9
50/150 Hz ratio (%) 79 ± 12 84 ± 10 77 ± 11 85 ± 9
Values for age, body weight, BMI, MMT sum score, and pre-fatigue characteristics are mean ± SD; values for age at acute polio, present walking distance
and MMT knee extension are median (range).
Abbreviations: BMI, body mass index; MMT, manual muscle testing; MVT, maximal voluntary torque; RT50, half-relaxation time.
a Walking distance was classiﬁed in 4 categories: 1 = indoors only; 2 = around the house; 3 = seldom further than 1 km; 4 = regularly further than 1 km.
b Sum score for the muscle strength of the legs was calculated by adding 16 muscle groups. Each muscle group had a score between 0 and 5, sum score
ranged from 0 to 80 [33].
c p 6 0.001 (PPS versus control subjects, in the total study group).
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The MVT of the knee extensor muscles of patients with
PPS was signiﬁcantly lower compared to healthy subjects
(mean diﬀerence 74 Nm, 95% CI 96 to 51,
p 6 0.001). In 20 of the 26 female patients MVT was
below the lowest value found in the healthy women
(128 Nm), and 11 of the 12 male patients had an MVT
below the lowest value found in healthy men (150 Nm).
No signiﬁcant diﬀerences in pre-fatigue state with respect
to contractile speed (RT50 and 50/150 Hz ratio) were
found between both groups (Table 1).3.3. Fatigue resistance
The relative torque level during the initial contraction of
the fatigue protocol was comparable in PPS and healthy
subjects (33.4 ± 9.3% MVT versus 30.8 ± 5.6% MVT,
p = 0.300). No diﬀerence was found between both groups
with respect to the course of fatigue (p = 0.780). During
the protocol torque declined to 50.6 ± 10.5% in the last
contraction in patients with PPS and to 52.2 ± 11.9% in
healthy subjects (Fig. 1A).
No diﬀerence in slowing of relaxation during the fatigue
protocol was found between PPS and healthy subjects.
After an initial increase in RT50 during the ﬁrst 40
contractions, muscles of both groups showed a gradual
decrease towards the end of the protocol (Fig. 1B). In the
last contraction of the protocol, RT50 was increased by32.5 ± 17.5% in the PPS group compared to
34.2 ± 16.0% in the control group (p = 0.366).
All subjects (n = 20) continued the protocol under
occlusion for at least 70 contractions. Therefore the 70th
contraction was used as the last contraction in the
analysis (Fig. 2). During the protocol, torque declined to
24.9 ± 14.5% in patients with PPS and to 28.8 ± 7.2% in
healthy subjects (p = 0.173). When compared to the
torque decrease with intact blood circulation, the
additional decrease in peak torque as a consequence of
the occluded blood ﬂow was similar in the PPS
(25.0 ± 11.8% at the last contraction) and control group
(31.1 ± 12.0%) (p = 0.802).
3.4. Recovery
Recovery from the reduction in peak torque during the
fatigue protocol was better in patients with PPS compared
to healthy subjects (p = 0.043). The recovery was however
incomplete in both groups. In muscles from healthy
subjects, only 54.9 ± 20.4% of the reduction in torque
during the fatigue protocol recovered within 3 min, while
patients with PPS recovered to 68.9 ± 20.5% of the
reduction (Fig. 3A).
Although still incomplete, RT50 recovered to a higher
extent compared to torque (Fig. 3B) and no diﬀerence
was found between PPS and healthy subjects (p = 0.138).
In patients with PPS 85.9 ± 21.0% of the increase in
RT50 during the fatigue protocol recovered within 3 min,
compared to 86.7 ± 19.0% in the healthy subjects.
Fig. 1. Changes in parameters during the standard fatigue protocol with
an intact circulation. Peak torque (A) and half-relaxation time (B) are
expressed as percentages of pre-fatigue values (=100%). Mean data ± SD
are shown for every ﬁfth contraction for PPS (h; n = 36) and control
subjects (d; n = 17).
Fig. 2. Change in peak torque during the fatigue protocol under arterial
occlusion. Values are expressed as percentages of pre-fatigue value
(=100%). Mean data ± SD are shown for every ﬁfth contraction for
PPS (h; n = 9) and control subjects (d; n = 11).
Fig. 3. Recovery of parameters following the standard fatigue protocol
with an intact circulation. Peak torque (A) and half-relaxation time (B) are
expressed as percentages of the change during the fatigue protocol
(=100%). Mean data ± SD are shown for every ﬁfth contraction for PPS
(h; n = 34) and control subjects (d; n = 16).
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Comparing results of patients reporting abnormal
increased muscle fatigability (n = 23) in the measured legto those without this complaint (n = 15), revealed no
signiﬁcant diﬀerences with respect to any of the studied
variables, except for the slowing of relaxation, showing
less change in the group with fatigue complaints
(p = 0.031).4. Discussion
Contrary to our expectations no diﬀerences in fatigue
resistance of the knee extensor muscles between patients
with PPS and healthy control subjects were found,
indicating that the abnormal muscle fatigue reported by
many patients with PPS is most likely explained by
factors other than impaired intrinsic fatigability of the
muscle ﬁbers.
Fatigue resistance is determined by the interplay of
energy utilisation and energy production. During
prolonged series of stimulated contractions, the
production of energy depends largely on aerobic
metabolism. Several observations from the present study
showed that for the knee extensor muscles in PPS,
neither the rate of energy utilisation is higher, nor the
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normal. The ﬁrst important observation to support this
conclusion is that the rate of fatigue was comparable in
patients with PPS and healthy subjects both in the
situation with intact circulation and when the blood ﬂow
was occluded (Figs. 1A and 2). Contrary to ﬁndings in
muscle biopsies from patient with PPS that showed a
reduced capillary supply and oxidative enzyme activity
[5,23], this indicates that impaired blood ﬂow or reduced
aerobic capacity of the muscle ﬁbers does not contribute
to the abnormal muscle fatigue perceived by these
patients. This is further supported by the recovery
measurements, where no diﬀerences were found between
PPS and healthy subjects with respect to recovery of
half-relaxation time, and an even faster and more
complete recovery of peak torque in patients with PPS
(Fig. 3A and B). Although the explanation for the latter
ﬁnding remains unclear, these results argue against a
compromised aerobic metabolism in PPS muscles, since
recovery depends to a large extent on the aerobic
capacity of the muscle ﬁbers [21].
In addition, we found no indications that the rate at
which energy was utilised was higher in knee extensor
muscles of patients with PPS compared to healthy
subjects. One way to investigate this is by comparing the
extent of fatigue under occlusion between both groups. In
this situation blood ﬂow to the muscles is restricted and
consequently fatigue will be determined primarily by
anaerobic energy utilisation since aerobic energy
regeneration is no longer possible [17]. Our results
showed that fatigability under occlusion was comparable
in PPS and healthy subjects (Fig. 2) and therefore suggest
that the speed of energy utilisation is similar in both
groups. This is consistent with the ﬁndings regarding the
half-relaxation time and the 50/150 Hz ratio which were
measured in the pre-fatigue state as indices of contractile
speed. Compared to type II ﬁbers, type I ﬁbers have a
slower speed of contraction and consequently a slower
rate of energy consumption. Therefore, the absence of
signiﬁcant diﬀerences in these parameters suggests that
large dissimilarities in muscle ﬁber type composition of
the tested knee extensor muscles, between PPS and
healthy subjects are not likely.
Our ﬁndings of no diﬀerences in contractile properties
and aerobic capacity of the muscle ﬁbers between both
groups were unexpected given the muscular adaptations
and fatigability complaints that have been described in
patients with PPS [4–6]. This may indicate that our study
group was not representative for the PPS population.
However, based on the considerably lower muscle
strength, low physical activity level, and complaints of
generalized fatigue and local muscle fatigue in the
majority of patients, which is consistent with
characteristics that are known in the literature [24,25],
this seems unlikely. The clinical relevance of these
opposite adaptations has been debated before [3,5,6,26]
and it may well be that the combination of adaptations,such as the predominance of type I ﬁbers with a
decreased oxidative enzyme activity, ultimately has no
eﬀect on the fatigability of the muscle ﬁbers in patient
with PPS.
A methodological limitation is the small subgroup that
performed the occlusion measurements. Nevertheless,
despite the limited sample size, characteristics of these
patients did not diﬀer from the characteristics of the
other patients, indicating that they formed a
representative subgroup. Furthermore, all patients
suﬀered from generalized fatigue, and MVT of the knee
extensor muscles was below the lowest values found in
healthy subjects in 82% of the patients, indicating that
the majority of measured legs were clinically aﬀected.
Part of the patients, however, reported no complaints of
abnormal muscle fatigability in the measured leg.
Nevertheless, further analyses revealed that, except for
the slowing of relaxation, there were no diﬀerences
between patients with abnormal muscle fatigue
complaints in the measured leg compared to those
without this complaint. In addition, it should be realized
that neuromuscular adaptations have also been found in
clinically unaﬀected muscles and therefore this probably
did not negatively inﬂuence generalizibility of results
[27–29].
With the present study we have shown that the muscle
fatigue complaints reported by many patients with PPS
are most likely explained by factors other than intrinsic
fatigability of the muscle ﬁbers. Previous studies that
investigated the contribution of central fatigue indicate
that an impaired voluntary activation does not seem to
be a major factor as well [8,13], but evidence is limited,
and therefore this factor should be considered [3,30].
Another possible explanation, which has been proposed
before [3,13,31], is that perceived fatigue is mainly related
to a reduced muscle mass. Given the substantially lower
maximal isometric knee extensor muscle strength (41%)
that we found in PPS compared to healthy subjects, it is
reasonable to assume that the relatively higher loading of
active muscles contributes to the increase in muscle
fatigue in executing daily life activities [32].
In conclusion, the present study did not ﬁnd diﬀerences
in fatigue resistance of electrically activated knee extensor
muscles between patients with PPS and a healthy control
group. Our ﬁndings suggest that there are no diﬀerences
with respect to contractile properties and aerobic muscle
capacity that contribute to the increased muscle fatigue
reported by many patients with PPS during daily life
activities. Probably, this symptom is most likely the result
of muscle weakness that requires individuals to perform
at higher relative muscle load, inducing early fatigue.
Acknowledgements
Author contributions: E.V. collected data, performed
data analyses, contributed to discussion, and wrote the
manuscript. A.B. assisted with data analyses, contributed
898 E.L. Voorn et al. / Neuromuscular Disorders 23 (2013) 892–898to discussion, and reviewed/edited the manuscript. K.G.
contributed to discussion and reviewed/edited the
manuscript. F.N. contributed to discussion and reviewed/
edited the manuscript. A.H. contributed to discussion
and reviewed/edited the manuscript.
This study was supported by the Prinses Beatrix
Spierfonds (PBF); The Dutch Public Fund for
Neuromuscular Disorders, The Netherlands Organization
for Health Research and Development (ID: ZonMW
89000003) and the Department of Rehabilitation AMC.References
[1] March of Dimes. International conference on post-polio syndrome:
identifying best practices in diagnosis & care. White Plains, NY,
USA; 2000.
[2] Tersteeg IM, Koopman FS, Stolwijk-Swuste JM, Beelen A, Nollet F.
A 5-year longitudinal study of fatigue in patients with late-onset
sequelae of poliomyelitis. Arch Phys Med Rehabil
2011;92(6):899–904.
[3] Thomas CK, Zijdewind I. Fatigue of muscles weakened by death of
motoneurons. Muscle Nerve 2006;33(1):21–41.
[4] Birk TJ. Poliomyelitis and the post-polio syndrome: exercise
capacities and adaptation–current research, future directions, and
widespread applicability. Med Sci Sports Exerc 1993;25(4):466–72.
[5] Borg K, Henriksson J. Prior poliomyelitis-reduced capillary supply
and metabolic enzyme content in hypertrophic slow-twitch (type I)
muscle ﬁbres. J Neurol Neurosurg Psychiatry 1991;54(3):236–40.
[6] Grimby G, Einarsson G, Hedberg M, Aniansson A. Muscle adaptive
changes in post-polio subjects. Scand J Rehabil Med
1989;21(1):19–26.
[7] Allen GM, Gandevia SC, Neering IR, Hickie I, Jones R, Middleton J.
Muscle performance, voluntary activation and perceived eﬀort in
normal subjects and patients with prior poliomyelitis. Brain
1994;117(Pt 4):661–70.
[8] Allen GM, Middleton J, Katrak PH, Lord SR, Gandevia SC.
Prediction of voluntary activation, strength and endurance of elbow
ﬂexors in postpolio patients. Muscle Nerve 2004;30(2):172–81.
[9] Sharma KR, Kent-Braun J, Mynhier MA, Weiner MW, Miller RG.
Excessive muscular fatigue in the postpoliomyelitis syndrome.
Neurology 1994;44(4):642–6.
[10] Agre JC, Rodriquez AA. Neuromuscular function: comparison of
symptomatic and asymptomatic polio subjects to control subjects.
Arch Phys Med Rehabil 1990;71(8):545–51.
[11] Samii A, Lopez-Devine J, Wasserman EM, et al. Normal postexercise
facilitation and depression of motor evoked potentials in postpolio
patients. Muscle Nerve 1998;21(7):948–50.
[12] Sunnerhagen KS, Carlsson U, Sandberg A, Stalberg E, Hedberg M,
Grimby G. Electrophysiologic evaluation of muscle fatigue
development and recovery in late polio. Arch Phys Med Rehabil
2000;81(6):770–6.
[13] Grimby G, Stalberg E, Sandberg A, Sunnerhagen KS. An 8-year
longitudinal study of muscle strength, muscle ﬁber size, and dynamic
electromyogram in individuals with late polio. Muscle Nerve
1998;21(11):1428–37.[14] Burke RE, Levine DN, Tsairis P, Zajac III FE. Physiological types
and histochemical proﬁles in motor units of the cat gastrocnemius. J
Physiol 1973;234(3):723–48.
[15] Harridge SD, Bottinelli R, Canepari M, et al. Whole-muscle and
single-ﬁbre contractile properties and myosin heavy chain isoforms in
humans. Pﬂugers Arch 1996;432(5):913–20.
[16] Grimby G, Jonsson AL. Disability in poliomyelitis sequelae. Phys
Ther 1994;74(5):415–24.
[17] Russ DW, Elliott MA, Vandenborne K, Walter GA, Binder-Macleod
SA. Metabolic costs of isometric force generation and maintenance of
human skeletal muscle. Am J Physiol Endocrinol Metab
2002;282(2):E448–57.
[18] Koopman FS, Beelen A, Gerrits KH, et al. Exercise therapy and
cognitive behavioural therapy to improve fatigue, daily activity
performance and quality of life in postpoliomyelitis syndrome: the
protocol of the FACTS-2-PPS trial. BMC Neurol 2010;10:8.
[19] Gerrits HL, De Haan A, Hopman MT, van der Woude LH, Jones
DA, Sargeant AJ. Contractile properties of the quadriceps muscle in
individuals with spinal cord injury. Muscle Nerve 1999;22(9):1249–56.
[20] Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular
mechanisms. Physiol Rev 2008;88(1):287–332.
[21] Blei ML, Conley KE, Odderson IB, Esselman PC, Kushmerick MJ.
Individual variation in contractile cost and recovery in a human
skeletal muscle. Proc Natl Acad Sci U S A 1993;90(15):7396–400.
[22] Wust RC, Morse CI, De Haan A, Jones DA, Degens H. Sex
diﬀerences in contractile properties and fatigue resistance of human
skeletal muscle. Exp Physiol 2008;93(7):843–50.
[23] Grimby L, Tollback A, Muller U, Larsson L. Fatigue of chronically
overused motor units in prior polio patients. Muscle Nerve
1996;19(6):728–37.
[24] Trojan DA, Cashman NR. Post-poliomyelitis syndrome. Muscle
Nerve 2005;31(1):6–19.
[25] Gonzalez H, Olsson T, Borg K. Management of postpolio syndrome.
Lancet Neurol 2010;9(6):634–42.
[26] Nordgren B, Falck B, Stalberg E, et al. Postpolio muscular
dysfunction: relationships between muscle energy metabolism,
subjective symptoms, magnetic resonance imaging,
electromyography, and muscle strength. Muscle Nerve
1997;20(11):1341–51.
[27] Grabljevec K, Burger H, Kersevan K, Valencic V, Marincek C.
Strength and endurance of knee extensors in subjects after paralytic
poliomyelitis. Disabil Rehabil 2005;27(14):791–9.
[28] Luciano CA, Sivakumar K, Spector SA, Dalakas MC.
Electrophysiologic and histologic studies in clinically unaﬀected
muscles of patients with prior paralytic poliomyelitis. Muscle Nerve
1996;19(11):1413–20.
[29] McComas AJ, Quartly C, Griggs RC. Early and late losses of motor
units after poliomyelitis. Brain 1997;120(Pt 8):1415–21.
[30] Abraham A, Drory VE. Fatigue in motor neuron diseases.
Neuromuscul Disord 2012;22(Suppl. 3):S198–202.
[31] Nollet F, Beelen A, Sargeant AJ, de Visser M, Lankhorst GJ, de Jong
BA. Submaximal exercise capacity and maximal power output in
polio subjects. Arch Phys Med Rehabil 2001;82(12):1678–85.
[32] Frey Law LA, Avin KG. Endurance time is joint-speciﬁc: a modelling
and meta-analysis investigation. Ergonomics 2010;53(1):109–29.
[33] Medical Research Council. Aids to examination of the peripheral
nervous system. Memorandum no. 45. London: Her Majesty’s
Stationary, Oﬃce, 1976.
